Amends the current law on controlled substances to permit a person to be in possession of less than one ounce of psilocybin and permits psilocybin to be securely cultivated within a person's residence for personal use.
Requires sentencing court to consider whether defendant is parent of child, or caregiver of elderly, disabled or terminally ill person whose well-being would be adversely affected by the person's incarceration and if so, shall impose a non-jail sentence.
Provides employees with civil administrative remedies against contractors, subcontractors involved in the contract with joint/severable liability imposed on contractors or subcontractors. Effective 9/1/2024.
Provides that upon application, and good cause, the state may waive the bonding requirement for certified minority business enterprises or women owned businesses.
Requires state use actual residences of persons in government custody for redistricting purposes. Information would be collected by the department of corrections and forwarded to the secretary of state to be utilized for redistricting.
Prohibits any questioning of a juvenile who is suspected of delinquent or criminal behavior, unless the parent of guardian of the juvenile is present, or unless an attorney is present or the juvenile and their parents have waived their presence.
Establishes the process to provide a legal mechanism whereby a terminally ill patient may choose to end their life using medications prescribed by a physician.
Establishes the second look act and would permit incarcerated individuals to petition the sentencing court to consider a motion to reduce a sentence after the defendant has served at least ten (10) years of the sentence.
Prohibits a health insurer from denying a claim for any medical bill based on sole reasoning that the bill may arise from a motor vehicle accident or other third-party claim and prohibits a medical provider from refusing to submit medical for same reason.
Caps the total amount that a covered person is required to pay for a covered prescription asthma inhaler to twenty-five dollars ($25.00) per thirty (30) day supply.